BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q4 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $214,000 | -31.6% | 11,200 | +14.3% | 0.01% | -36.4% |
| Q2 2021 | $313,000 | -4.9% | 9,800 | +60.7% | 0.01% | -35.3% |
| Q3 2020 | $329,000 | -11.6% | 6,100 | 0.0% | 0.02% | -19.0% |
| Q2 2020 | $372,000 | +32.9% | 6,100 | 0.0% | 0.02% | +5.0% |
| Q1 2020 | $280,000 | -47.7% | 6,100 | 0.0% | 0.02% | -33.3% |
| Q4 2019 | $535,000 | +110.6% | 6,100 | +205.0% | 0.03% | +87.5% |
| Q2 2019 | $254,000 | -19.4% | 2,000 | 0.0% | 0.02% | -20.0% |
| Q1 2019 | $315,000 | +7.9% | 2,000 | 0.0% | 0.02% | +17.6% |
| Q3 2018 | $292,000 | -7.0% | 2,000 | 0.0% | 0.02% | -10.5% |
| Q2 2018 | $314,000 | -8.2% | 2,000 | 0.0% | 0.02% | -13.6% |
| Q1 2018 | $342,000 | -23.1% | 2,000 | -20.0% | 0.02% | -21.4% |
| Q4 2017 | $445,000 | +38.6% | 2,500 | -50.0% | 0.03% | -80.3% |
| Q4 2015 | $321,000 | – | 5,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |